Rapid Communication
Copyright ©2007 Baishideng Publishing Group Inc.
World J Gastroenterol. Nov 7, 2007; 13(41): 5465-5470
Published online Nov 7, 2007. doi: 10.3748/wjg.v13.i41.5465
Figure 1
Open in New Tab Full Size Figure Download Figure
Figure 1 Cumulative survival of patients with hepatocellular carcinoma accompanied by PVTT who treated combination therapy.
Figure 2
Open in New Tab Full Size Figure Download Figure
Figure 2 Survival of patients with hepatocellular carcinoma accompanied by PVTT according to the response and control (Log-rank P < 0. 05). CR: Complete response, PR; Partial response, NC; No change, PD; Progressive disease.
Figure 3
Open in New Tab Full Size Figure Download Figure
Figure 3 Survival of patients with hepatocellular carcinoma accompanied by PVTT according to Child-Pugh's stage (Log-rank P = 0. 98).
  • Citation: Ishikawa T, Imai M, Kamimura H, Tsuchiya A, Togashi T, Watanabe K, Seki KI, Ohta H, Yoshida T, Kamimura T. Improved survival for hepatocellular carcinoma with portal vein tumor thrombosis treated by intra-arterial chemotherapy combining etoposide, carboplatin, epirubicin and pharmacokinetic modulating chemotherapy by 5-FU and enteric-coated tegafur/uracil: A pilot study. World J Gastroenterol 2007; 13(41): 5465-5470
  • URL: https://www.wjgnet.com/1007-9327/full/v13/i41/5465.htm
  • DOI: https://dx.doi.org/10.3748/wjg.v13.i41.5465